Business Description
Solid Biosciences is a US-based biotechnology company focused on developing treatments for serious muscle and heart conditions, including Duchenne muscular dystrophy, Friedreich's ataxia, and several rare cardiac diseases. The company is advancing multiple drug candidates across various stages of development, from early discovery through clinical trials. Solid Biosciences also builds the underlying delivery and gene-expression technologies that support these programs, and works alongside partners such as Ultragenyx Pharmaceutical and several leading universities to bring new therapies to patients.
